Related by context. All words. (Click for frequent words.) 71 T2DM 66 ADPKD 66 elevated triglyceride levels 66 microalbuminuria 65 MetS 65 subclinical atherosclerosis 65 diabetes mellitus DM 64 colorectal adenoma 64 heterozygotes 64 TT genotype 64 metabolic syndrome MetS 64 sporadic ALS 64 T1DM 64 PCa 64 prostate cancer CaP 63 esophageal squamous cell carcinoma 63 genetic polymorphisms 63 abdominal adiposity 63 rs# [002] 63 APOE e4 63 genetic variants associated 63 autonomic dysfunction 63 5 HTTLPR 63 lipid abnormalities 62 rs# [004] 62 CC genotype 62 colorectal neoplasia 62 ABCB1 62 hypertensives 62 2 diabetes T2D 62 nondiabetic 62 MGUS 62 SSc 62 rs# [003] 62 CETP gene 62 Haptoglobin 62 atherosclerotic lesions 62 hyperglycaemia 62 basal cell nevus syndrome 62 systemic lupus erythematosus SLE 61 tHcy 61 PTPN# 61 serum lipid levels 61 arterial thickening 61 NAFLD 61 LV dysfunction 61 macroalbuminuria 61 MYH9 gene 61 macrovascular disease 61 dysglycemia 61 insulin resistance syndrome 61 Lp PLA2 61 adiponectin concentrations 61 prostate carcinogenesis 61 familial hypercholesterolemia 61 APOE gene 61 dyslipidaemia 61 CYP#C# gene 61 carotid plaques 61 atherosclerotic disease 61 gallstone disease 61 serum IGF 61 atopy 61 CVD mortality 61 liver fibrosis 61 HER2 overexpression 61 gene polymorphism 61 intact parathyroid hormone 61 VKORC1 61 clinicopathological 61 SNP rs# [001] 61 renal fibrosis 61 subclinical hypothyroidism 61 HNPCC 61 HIV HCV coinfected 61 APOE genotype 60 cardiometabolic risk 60 multivariate logistic regression 60 PsA 60 kidney allograft 60 nonalcoholic steatohepatitis NASH 60 TCF#L# 60 atherogenic dyslipidemia 60 APOE ε4 60 elevated triglycerides 60 atherothrombotic disease 60 atrophic gastritis 60 CYP#C# [001] 60 allele frequencies 60 amnestic MCI 60 isolated systolic hypertension 60 familial ALS 60 MTHFR 60 serum urate levels 60 GSTM1 60 airway hyperresponsiveness 60 carotid plaque 60 glycated hemoglobin levels 60 dopamine receptor gene 60 cystatin C 60 gastric carcinogenesis 60 insulin resistance 60 nitrotyrosine 60 obesity insulin resistance 60 coronary calcification 60 metabolic syndrome 60 systolic hypertension 60 IPAH 60 apolipoprotein B 60 lipid levels 60 hypercholesterolaemia 60 chronic hepatitis cirrhosis 60 nondemented 60 diabetes mellitus T2DM 60 familial pancreatic cancer 60 susceptibility loci 60 carotid IMT 60 fasting glucose levels 60 apo B 60 Parkinson disease PD 60 genetic loci 60 Lp PLA 2 60 proliferative diabetic retinopathy 60 type2 diabetes 60 endothelial dysfunction 60 HNSCC 60 postoperative AF 60 Clusterin 60 HOMA IR 60 logistic regression analysis 59 germline mutations 59 cardioembolic stroke 59 metabolic abnormalities 59 hyperhomocysteinemia 59 multivariate Cox 59 lipoprotein levels 59 hepatic fibrosis 59 Hp2 2 59 CSF biomarkers 59 HDL2 59 nonfasting triglyceride levels 59 G6PD deficiency 59 thyrotropin 59 Severe Primary IGFD 59 plasma kallikrein 59 multivariable adjusted 59 Sjögren syndrome 59 CDH1 59 colorectal carcinoma 59 IL#R 59 amyloid deposition 59 homozygotes 59 impaired glucose tolerance 59 gastric cardia 59 AAT deficiency 59 advanced adenoma 59 knee osteoarthritis OA 59 PTEN mutations 59 serum PTH 59 GH deficiency 59 PAOD 59 diastolic function 59 K ras mutations 59 diabetes mellitus 59 recurrent VTE 59 poor metabolizers 59 IDH1 mutation 59 motor neuron degeneration 59 IDDM 59 subclinical hyperthyroidism 59 monogenic 59 haplotypes 59 cardiac dysfunction 59 adrenal function 59 behavioral disinhibition 59 elevated homocysteine 59 progressive neurodegenerative disorder 59 elevated LDL cholesterol 59 euthymic patients 59 HDL C 59 APOL1 59 genomewide 59 cardiovascular morbidity 59 untreated celiac disease 59 hydroxyvitamin D levels 59 elevated CRP 59 atherothrombotic 59 primary biliary cirrhosis 59 breast cancer metastasis 59 exfoliation glaucoma 59 clusterin 59 Framingham Risk Score 58 adiponectin levels 58 cerebral infarction 58 urolithiasis 58 Genetic variants 58 PON1 58 lupus anticoagulant 58 IL 1ß 58 penetrance 58 Leydig cell 58 apolipoprotein E gene 58 colorectal cancer CRC 58 HMGA1 58 conditional logistic regression 58 nephropathy 58 EoE 58 Aortic stenosis 58 FTLD 58 impaired fasting glucose 58 HbA 1c 58 prostate cancer PCa 58 hypovitaminosis D 58 amnestic mild cognitive impairment 58 CNTNAP2 58 atherosclerosis 58 apoC III 58 nonvertebral fracture 58 gene polymorphisms 58 NNRTI resistance 58 HBeAg negative 58 colorectal tumors 58 Reynolds Risk Score 58 metabolic parameters 58 T1D 58 atherogenic 58 diabetes dyslipidemia 58 CagA 58 HLA B# 58 CP CPPS 58 proband 58 rs# [001] 58 STAT4 58 LRP5 58 metabolic disturbances 58 thyrotropin levels 58 serum uric acid 58 neuroinflammation 58 hypercholesterolemia 58 colorectal polyps 58 tic severity 58 DRD2 58 CMV infection 58 overt hypothyroidism 58 SLC#A# [002] 58 albumin excretion 58 homozygote 58 fasting insulin 58 IL#B 58 fetuin 58 CYP#D# 58 premorbid 58 neovascular 58 SMAD4 58 basal cell carcinoma BCC 58 MTHFR gene 58 carotid atherosclerosis 58 intensive statin therapy 58 differential gene expression 58 alanine aminotransferase ALT 58 homocysteine concentrations 58 antihypertensive therapy 58 transgenic mouse models 58 atopic 58 MSH2 58 SNP rs# [002] 58 serum cholesterol 58 symptomatic VTE 58 serum selenium 58 inflammatory biomarkers 58 chronic periodontitis 58 GABRA2 58 spinocerebellar ataxia 58 triacylglycerol concentrations 58 COMT gene 58 β blockers 58 urate levels 58 GISTs 58 C#Y 57 telomere lengths 57 atherothrombosis 57 bexarotene 57 severe periodontitis 57 pyridostigmine 57 TCF#L# gene 57 psoriatic arthritis PsA 57 allelic variants 57 LV hypertrophy 57 lupus nephritis 57 microvascular disease 57 familial clustering 57 methylenetetrahydrofolate reductase 57 narcolepsy cataplexy 57 atopic disorders 57 mtDNA mutations 57 LRAT 57 MLH1 57 apolipoproteins 57 CHD mortality 57 HLA DR 57 serum GGT 57 ORMDL3 57 antioxidant supplementation 57 Logistic regression 57 androgen deficiency 57 NF1 57 Gorlin syndrome 57 GBA mutations 57 metabolic dysfunction 57 periprocedural MI 57 HLA DRB1 57 definite stent thrombosis 57 colorectal adenomas 57 mRNA expression 57 sCJD 57 abnormal lipid 57 serum triglycerides 57 liver histology 57 EBV infection 57 hereditary hemochromatosis 57 APOC3 57 miRs 57 cardiovascular disease CVD 57 pancreatic adenocarcinoma 57 dietary intakes 57 etiologic 57 glycemia 57 thromboembolism 57 hsCRP 57 elevated IOP 57 prolonged QT interval 57 LPS induced 57 #q# [001] 57 adenoma recurrence 57 cardio metabolic 57 normotensive 57 diabetic nephropathy 57 alcoholic fatty liver 57 glitazones 57 impaired endothelial 57 cardiovascular mortality 57 HbF 57 KIF6 carriers 57 nonmelanoma skin cancers 57 recurrent miscarriage 57 confidence interval #.#-#.# 57 Prehypertension 57 ximelagatran 57 alexithymia 57 cirrhotic patients 57 atherosclerotic cardiovascular disease 57 TEAEs 57 ApoE gene 57 serum lipids 57 generalized epilepsy 57 atypical hyperplasia 57 β amyloid 57 olmesartan 57 plasma folate 57 neuroprotective effects 57 retrospective cohort 57 catechol O methyltransferase 57 thrombophilia 57 Alzheimer disease AD 57 C1q 57 MYH9 57 IgA deficiency 57 ALDH2 57 lipoprotein 57 APOE e4 gene 57 immunocompetent 57 cystatin 57 HbA1c levels 57 HbA1C levels 57 liver transplant recipients 57 plasma lipoprotein 57 undergoing radical prostatectomy 57 chromosomal rearrangement 57 hyperinsulinemia 57 VEGF receptor 57 microdeletions 57 postoperative pulmonary 57 natriuretic peptide 57 airway hyper responsiveness 57 promoter polymorphism 57 PSADT 57 neuropathologic 57 atherosclerotic progression 57 ApoE4 57 Fas ligand 57 stratifying patients 57 GSTT1 57 APOE allele 57 disease NAFLD 57 microsatellite instability 57 cardioprotective effects 57 polycystic ovary syndrome PCOS 57 gene APOE 57 SGPT 57 chromosome #p# [001] 57 nicotinic receptor 57 nonalcoholic steatohepatitis 57 multivariable analysis 57 underlying pathophysiology 57 neurocognitive impairment 57 SRBD 57 arterial stiffness 57 ApoE 57 abnormal glucose metabolism 57 Alzheimer Disease AD 57 latent celiac disease 57 unmeasured confounders 57 renal tumors 57 PDGFR 57 logistic regression model 57 CAG repeats 57 cardiomyopathies 57 microvascular complications 57 cardiac hypertrophy 57 serum phosphate 57 lipid lowering medications 57 FGFR1 57 APOE4 57 IKZF1 57 Cardiotoxicity 57 homozygosity 57 nondepressed 57 choroidal neovascularization 57 Diabetic nephropathy 57 islet autoimmunity 57 Statin therapy 57 Logistic regression analysis 57 prognostic significance 57 polymorphisms 57 LQTS 57 neuropsychiatric disorder 57 protein tyrosine phosphatase 56 testosterone supplementation 56 inflammatory polyarthritis 56 clinico pathological 56 antidiabetic medication 56 elevated uric acid 56 parkinsonism 56 BMI z 56 nonfatal MI 56 mitochondrial mutations 56 proliferative retinopathy 56 susceptibility gene 56 mycophenolate mofetil 56 nondiabetic patients 56 Alzheimers disease 56 INTERHEART study 56 primary aldosteronism 56 variant rs# 56 Kaplan Meier curve 56 HeFH 56 FeNO 56 ependymomas 56 KIBRA 56 lipid parameters 56 SHPT 56 plasma lipid 56 coronary heart 56 acetabular dysplasia 56 relapsed MM 56 Apolipoprotein E 56 prothrombotic 56 hepatic cirrhosis 56 candesartan 56 Univariate analysis 56 LUTS 56 pathophysiological mechanisms 56 knee OA 56 PICALM 56 IFN beta 56 HoFH 56 left ventricular diastolic 56 serous ovarian cancer 56 postmenopausal breast cancer 56 Chronic pancreatitis 56 serum concentrations 56 missense mutations 56 albuminuria 56 malignant lymphoma 56 receptor inhibitor 56 aMCI 56 hepatocellular carcinomas 56 ERBB2 56 Darapladib 56 serum lipid 56 comorbid disorders 56 left ventricular hypertrophy 56 androgenic alopecia 56 ZNF# 56 CIN2 + 56 alpha synuclein protein 56 carotid stenosis 56 bioavailable testosterone 56 proteinuria 56 diabetic microvascular complications 56 contrast induced nephropathy 56 bronchial hyperresponsiveness 56 CNVs 56 humanin 56 polyp recurrence 56 biochemical recurrence 56 serum ferritin 56 isoenzymes 56 bronchopulmonary dysplasia BPD 56 leukemia AML 56 adenomatous polyps 56 Heritability 56 missense mutation 56 breast carcinoma 56 gastric adenocarcinoma 56 liver metastasis 56 chromosome #q# [001] 56 recurrent venous thromboembolism 56 Subgroup analyzes 56 aortic atherosclerosis 56 antidiabetic 56 NAT2 56 airway responsiveness 56 prospectively defined 56 familial aggregation 56 thromboembolic 56 SHBG levels 56 multivariable Cox 56 monozygotic twins 56 mitochondrial toxicity 56 methylation patterns 56 Endothelial dysfunction 56 S#A# [002] 56 eotaxin 56 autosomal dominant 56 Posiphen 56 prognostic variables 56 aminotransferase levels 56 genetic polymorphism 56 covariates 56 SCN5A 56 MDRD 56 triglyceride concentrations 56 alagebrium 56 S. maltophilia 56 spontaneous preterm delivery 56 malignant pleural mesothelioma 56 canakinumab 56 Multiple logistic regression 56 postoperative delirium 56 CaM kinase II 56 mutated K ras 56 lung adenocarcinoma 56 HER2 expression 56 SE alleles 56 hepatorenal syndrome 56 atopic eczema 56 nonischemic 56 ADAMTS# 56 univariate analyzes 56 extrapyramidal symptoms 56 hypogonadotropic hypogonadism 56 CARDIA 56 abnormal glucose tolerance 56 hallux valgus 56 KIF6 gene 56 aldehyde dehydrogenase 56 pramlintide 56 gene variants 56 familial AF 56 glomerular filtration 56 TPMT 56 VIPR2 56 cyclin E 56 pathogenetic 56 cardiac channelopathies 56 advanced neoplasia 56 serum BDNF 56 inherited mutations 56 medulloblastomas 56 Non Alcoholic Steatohepatitis 56 cranial irradiation 56 brain lesions 56 AUDs 56 onset diabetes mellitus 56 elevated LDL 56 genetic variant 56 HDL cholesterol triglycerides 56 PSA nadir 56 nonalcoholic fatty liver 56 GSTM1 gene 56 E selectin 56 leukemia ALL 56 interleukin IL -6 56 paroxysmal AF 56 arterial calcification 56 apolipoprotein E4 56 susceptibility genes 56 nonsense mutations 56 CrCl 56 neurodevelopmental impairment 56 mesotheliomas 56 BMPR2 56 proliferator activated receptor 56 apoE 56 antiproliferative effects 56 bile acid metabolism 56 transgene expression 56 GPx 56 psychiatric morbidity 56 neurocognitive function 56 affective psychoses 56 white matter hyperintensities 56 CYP# [002] 56 neuropsychiatric symptoms 56 antihypertensive drugs 56 bulimia nervosa 56 ApoE4 gene 56 reflux symptoms 56 lipid lowering drugs 56 cardiovascular disease 56 pancreatic neuroendocrine tumors 56 allelic 56 prognostic markers 56 monoclonal gammopathy 56 CIMZIA ™ 56 lactose malabsorption 56 elevated fasting glucose 56 cardiac autonomic 56 PIK3CA 56 TMEM#B 56 LPA gene 56 DNA methylation patterns 56 RBP4 56 gene locus 56 DQB1 * 56 hyperparathyroidism 56 statin medications 56 aneuploidies 56 collagen degradation 56 systolic dysfunction 55 chronicity 55 infarcts 55 antihypertensive medications 55 serum retinol 55 dopaminergic therapy 55 hypogonadal 55 UGT#A# * 55 urine NGAL 55 mammographic density 55 fasting plasma 55 testicular germ cell 55 genetic variation 55 perilipin 55 Hypertriglyceridemia 55 LDL cholesterol concentrations 55 dopamine transporter gene 55 isoprostane 55 NMIBC 55 antihypertensive medication 55 adenoma 55 nucleoside analogues 55 sulphonylureas 55 hypercoagulable 55 IGFBP 55 APTIVUS r 55 shorter telomere length 55 UCP2 55 PIGF 55 Cystatin C 55 advanced adenomas 55 Trandolapril 55 grade cervical intraepithelial 55 left ventricular dysfunction 55 endometrial carcinoma 55 paricalcitol 55 aminotransferases 55 C reactive protein 55 thromboembolic disease 55 LRRK2 gene 55 karyotypes 55 NNT = 55 LRRK2 mutations 55 vaso occlusive crisis 55 Genetic variation 55 depressive symptomatology 55 #p# [001] 55 cell adhesion molecule 55 ventricular remodeling 55 renal artery stenosis 55 overactive bladder symptoms 55 gastric cancers 55 hypoglycemic episodes 55 gastrointestinal GI bleeding 55 autistic traits 55 chemoresistant 55 NHANES III 55 CFH gene 55 diabetic retinopathy 55 perfusion abnormalities 55 HbA1C 55 intima media thickness 55 activated microglia 55 chromosomal alterations 55 PUFA intake 55 SCr 55 genotype 55 castrate resistant prostate cancer 55 LRRK2 mutation 55 osteosarcomas 55 hematopoietic cancers 55 Systemic Lupus Erythematosus 55 GSTP1 55 vildagliptin 55 atherosclerotic lesion 55 atherosclerotic vascular disease 55 adiposity 55 sitosterol 55 glomerular 55 anti fibrotic 55 myocardial infarction MI 55 tumor suppressor protein 55 virological response 55 FGFs 55 microbleeds 55 urinary symptoms 55 LTBI 55 V Leiden 55 chromium picolinate supplementation 55 myocardial ischemia 55 overt nephropathy 55 folate deficiency 55 WNK1 55 Myelodysplastic syndromes MDS 55 COMT 55 variceal bleeding 55 BRCA mutations 55 haematopoietic 55 glucose homeostasis 55 HLA DRB1 * 55 probands 55 cytokine interleukin 55 #p# [003] 55 periodontitis 55 juvenile idiopathic arthritis JIA 55 pathophysiological 55 transgenic rats 55 vascular dysfunction 55 vitamin D insufficiency 55 modifier genes 55 hypermethylation 55 glycemic variability 55 functional polymorphism 55 urothelial carcinoma 55 thiazolidinediones TZDs 55 IgE antibody 55 CCR5 delta# 55 QTLs 55 macrovascular complications 55 RRM1 55 pathogenic mechanisms 55 genetic variations 55 albumin excretion rate 55 prediabetes 55 urinary excretion 55 chromosome #q# [002] 55 corticosteroid dose 55 paralogs 55 IFN γ 55 nodal metastasis 55 coronary microvascular 55 soluble CD# ligand 55 XIENCE V PROMUS Stent 55 GH deficient 55 covariate 55 neuroregenerative 55 intravenous bisphosphonates 55 Framingham Offspring 55 galectin 3 55 neuropathological 55 lowest tertile 55 genes CYP#C# 55 extramedullary 55 HRQL 55 plasma fibrinogen 55 abdominal obesity 55 plasma pharmacokinetics 55 catechol O methyltransferase COMT 55 neurodegenerative disorder 55 heterozygous FH 55 Parkinson Disease PD 55 Fatty Liver Disease 55 paraneoplastic 55 potentially modifiable 55 TNF α 55 atherogenesis 55 pharmacologic intervention 55 Acute Myeloid Leukaemia AML 55 nonfasting triglycerides 55 secondary hyperparathyroidism 55 IL6 55 BRAF V#E 55 obstructive coronary artery 55 Framingham Offspring Study 55 glycated hemoglobin 55 genetic variants 55 CYP#D# gene 55 left ventricular systolic 55 apo E 55 TOP2A 55 serum creatinine levels 55 RAS mutations 55 fasting triglyceride levels 55 biochemical abnormalities 55 probiotic supplementation 55 neurocognitive deficits 55 acute leukemias 55 oesophageal adenocarcinoma 55 fluvastatin 55 transferrin saturation 55 serum parathyroid hormone 55 hypertensive patients 55 arachidonic acid AA 55 longitudinal cohort study 55 endometrial hyperplasia 55 post thrombotic syndrome 55 systemic lupus erythematosus 55 dyslipidemia 55 SGS# 55 tyrosine phosphorylation 55 attention-deficit/hyperactivity disorder ADHD 55 bronchopulmonary dysplasia 55 presymptomatic 55 nonobese 55 hyperlipidemia 55 uric acid levels 55 cutaneous melanoma 55 carcinoid 55 #q# deletion 55 melatonin receptor 55 renal allograft 55 cerebral microbleeds 55 sulfasalazine 55 astrocytomas 55 breast endometrial 55 vascular inflammation 55 HIV uninfected 55 proinflammatory cytokine 55 cardiolipin 55 pheochromocytoma 55 multigenic 55 multiple logistic regression 55 prostate carcinoma 55 cardiac fibrosis 55 cryptogenic 55 adverse cytogenetics 55 metabolite concentrations 55 C Reactive Protein 55 metastatic RCC 55 sCD# 55 Cognitive impairment 55 geographic atrophy 55 dysbindin 55 residual confounding 55 AREDS 55 hypercalciuria 55 plasma renin activity 55 plasma triglycerides 55 STK# gene 55 plasma adiponectin 55 MDM2 55 nNOS 55 troponin T 55 HIVAN 55 cTnT 55 SNCA 55 COX2 55 diastolic dysfunction 55 relapsed ALL 55 folate intake 55 androgen deprivation 55 diastolic hypertension 55 serum ALT 55 anterior uveitis 55 Insulin resistance 55 hepatocellular carcinoma 55 Nonalcoholic Fatty Liver Disease 55 carotid intima media 55 Natalizumab 55 NKX2 55 schizophrenia CIAS 55 Barrett esophagus BE 55 dexpramipexole 55 A1c levels 55 pelvic lymphadenectomy 55 modifiable lifestyle 55 psychiatric comorbidity 55 MIF gene 55 HGPS 55 gene variant 55 HBV infection 55 nephrogenic 55 serum calcium 55 intestinal polyps 55 MnSOD 55 HbA 1C 55 pro angiogenic 55 ductal adenocarcinoma 55 CYP#C# [002] 55 endothelial activation 55 Depressive symptoms 55 demyelinating 55 nonvertebral fractures 55 disease progression 55 primary hyperparathyroidism 55 serum TSH 55 colonic polyps 55 autosomal dominant disorder 55 serum vitamin D 55 effector function 55 estimated GFR 55 epithelial ovarian cancer 55 AST ALT 55 antidiabetic therapy 55 hematological parameters 55 serum folate concentrations 55 thrombotic complications 54 cardiac conduction 54 histone deacetylases 54 genotyped 54 leukotriene pathway 54 seminomas 54 nonmelanoma skin cancer 54 STRIDE PD 54 tertile 54 idiopathic myelofibrosis 54 gluten sensitive enteropathy 54 TNFa 54 G allele 54 membranous nephropathy 54 elevated ALT 54 CTAP# Capsules 54 macrovascular events 54 glucose intolerance 54 HMGA2 54 comorbid anxiety 54 interferon γ 54 neutralizing antibody 54 rheumatoid factor 54 monocyte chemoattractant protein 54 prognostic indicators 54 receptor antagonists 54 HPA axis 54 seropositivity 54 serum testosterone 54 renal impairment 54 triacylglycerol 54 baseline HbA1c 54 contrast echocardiography 54 carcinoembryonic antigen 54 NNRTIs 54 hypercalcemia 54 coagulation abnormalities 54 venous thrombosis 54 exhaled nitric oxide 54 hyperlipidaemia 54 serum leptin 54 Becker muscular dystrophy 54 prevalences 54 glycosylated hemoglobin HbA1c 54 beta carotene supplementation 54 serum calcium levels 54 microglial 54 clinically localized prostate 54 rheumatic diseases 54 mitochondrial function 54 nondiabetics 54 imatinib resistance 54 endophenotypes 54 comorbid depression 54 Dysregulation 54 LHON 54 Leukemias 54 HCV infection 54 phenotype 54 H. pylori infection 54 mitochondrial metabolism 54 haplotype 54 isoenzyme 54 neurological manifestations 54 epicardial adipose tissue 54 CaP 54 neovascular AMD 54 clinicopathologic 54 Hashimoto thyroiditis 54 Diabetes mellitus 54 coronary artery calcium 54 immunodeficiency 54 noncardiac